Patents by Inventor Mark A. Basinger

Mark A. Basinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5002755
    Abstract: Nephrotoxicity of anti-tumor platinum coordination compounds (e.g., cisplatin) is reduced by administering a dithiocarbamate chelator (e.g., diethyldithiocarbamate) at least 12 hours before as well as immediately after the administration of the anti-tumor compound.
    Type: Grant
    Filed: April 24, 1989
    Date of Patent: March 26, 1991
    Assignee: Vanderbilt University
    Inventors: William M. Mitchell, Mark M. Jones, Mark A. Basinger